CR20250018A - Derivados novedosos de indol sulfonamida 7 sustituidos - Google Patents
Derivados novedosos de indol sulfonamida 7 sustituidosInfo
- Publication number
- CR20250018A CR20250018A CR20250018A CR20250018A CR20250018A CR 20250018 A CR20250018 A CR 20250018A CR 20250018 A CR20250018 A CR 20250018A CR 20250018 A CR20250018 A CR 20250018A CR 20250018 A CR20250018 A CR 20250018A
- Authority
- CR
- Costa Rica
- Prior art keywords
- novel
- substituted indole
- sulfonamide derivatives
- indole sulfonamide
- w6quvbgz
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La invención se refiere a compuestos novedosos que tienen la fórmula general (I) ( <img alt="" src="data:image/png;base64,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 (***)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22187363 | 2022-07-28 | ||
| PCT/EP2023/070657 WO2024023128A1 (en) | 2022-07-28 | 2023-07-26 | Novel 7-substituted indole sulfonamide derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20250018A true CR20250018A (es) | 2025-03-03 |
Family
ID=82748322
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20250018A CR20250018A (es) | 2022-07-28 | 2023-07-26 | Derivados novedosos de indol sulfonamida 7 sustituidos |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP4562003A1 (es) |
| JP (1) | JP2025524062A (es) |
| KR (1) | KR20250043398A (es) |
| CN (1) | CN119585257A (es) |
| AR (1) | AR130023A1 (es) |
| AU (1) | AU2023315120A1 (es) |
| CA (1) | CA3261059A1 (es) |
| CL (1) | CL2025000125A1 (es) |
| CO (1) | CO2025002033A2 (es) |
| CR (1) | CR20250018A (es) |
| IL (1) | IL316865A (es) |
| MA (1) | MA71600A (es) |
| MX (1) | MX2025000822A (es) |
| PE (1) | PE20250849A1 (es) |
| TW (1) | TW202412800A (es) |
| WO (1) | WO2024023128A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2700773A (en) | 2024-05-23 | 2026-03-11 | Pheno Therapeutics Ltd | Compounds |
| GB2701173A (en) | 2024-05-23 | 2026-04-22 | Pheno Therapeutics Ltd | Compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3584244A1 (en) * | 2018-06-20 | 2019-12-25 | UCB Pharma GmbH | Substituted alkoxypyridinyl indolsulfonamides |
| JP2024507176A (ja) * | 2021-02-26 | 2024-02-16 | エフ． ホフマン－ラ ロシュ アーゲー | 新規なピリミジン－２－イルスルホンアミド誘導体 |
-
2023
- 2023-07-26 EP EP23748060.3A patent/EP4562003A1/en active Pending
- 2023-07-26 CN CN202380055096.9A patent/CN119585257A/zh active Pending
- 2023-07-26 WO PCT/EP2023/070657 patent/WO2024023128A1/en not_active Ceased
- 2023-07-26 CA CA3261059A patent/CA3261059A1/en active Pending
- 2023-07-26 IL IL316865A patent/IL316865A/en unknown
- 2023-07-26 AU AU2023315120A patent/AU2023315120A1/en active Pending
- 2023-07-26 AR ARP230101952A patent/AR130023A1/es unknown
- 2023-07-26 PE PE2025000192A patent/PE20250849A1/es unknown
- 2023-07-26 CR CR20250018A patent/CR20250018A/es unknown
- 2023-07-26 JP JP2025504084A patent/JP2025524062A/ja active Pending
- 2023-07-26 KR KR1020257001777A patent/KR20250043398A/ko active Pending
- 2023-07-26 MA MA71600A patent/MA71600A/fr unknown
- 2023-07-27 TW TW112128105A patent/TW202412800A/zh unknown
-
2025
- 2025-01-15 CL CL2025000125A patent/CL2025000125A1/es unknown
- 2025-01-21 MX MX2025000822A patent/MX2025000822A/es unknown
- 2025-02-24 CO CONC2025/0002033A patent/CO2025002033A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PE20250849A1 (es) | 2025-03-21 |
| KR20250043398A (ko) | 2025-03-28 |
| AR130023A1 (es) | 2024-10-23 |
| CA3261059A1 (en) | 2024-02-01 |
| EP4562003A1 (en) | 2025-06-04 |
| MA71600A (fr) | 2025-05-30 |
| CN119585257A (zh) | 2025-03-07 |
| TW202412800A (zh) | 2024-04-01 |
| IL316865A (en) | 2025-01-01 |
| CO2025002033A2 (es) | 2025-03-17 |
| AU2023315120A1 (en) | 2024-11-14 |
| CL2025000125A1 (es) | 2025-05-23 |
| MX2025000822A (es) | 2025-03-07 |
| WO2024023128A1 (en) | 2024-02-01 |
| JP2025524062A (ja) | 2025-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20250018A (es) | Derivados novedosos de indol sulfonamida 7 sustituidos | |
| CR20230410A (es) | Derivados novedosos de pirimidin-2-il-sulfonamida | |
| BR0212894A (pt) | Derivados de sulfeto de diarila, sais resultantes e agentes imunosupressores utilizando os mesmos | |
| BR0312570A (pt) | Seleção de interface em uma rede de comunicação sem fio | |
| BR112013021871A2 (pt) | lentes de contato de silicone hidrogel com níveis aceitáveis de perda de energia | |
| BR112018068208A2 (pt) | algoritmos de compensação de sensor óptico de nitrato para medição multiparamétrica da qualidade de água | |
| DE602004011358D1 (de) | (4-hydroxyphenyl)-1h-indol-3-carbaldehydoxim-derivative als östrogenagentien | |
| BRPI0409164A (pt) | pirazóis substituìdos | |
| CY1113029T1 (el) | Παραγωγα αζαδικυκλο [3.1.0] εξανιου χρησιμα ως ρυθμιστες υποδοχεων d3 ντοπαμινης | |
| BRPI0406556A (pt) | Sistema e métodos provendo modelo de segurança | |
| CY1110651T1 (el) | Παραγωγα της ν-'(1,5-διφαινυλ-1η- πυραζολ-3-υλ)μεθυλ σουλφοναμιδης με μια συγγενεια για τους υποδοχεις cb1 | |
| ATE440999T1 (de) | Verbesserungen betreffend optische aufheller | |
| CR20250058A (es) | Derivados novedosos deuterados de pirimidin-2-il sulfonamida | |
| CR20250019A (es) | Derivados novedosos de indol sulfonamida 7 sustituidos | |
| BR0213594A (pt) | Amidas de ácido nicotìnico e heterociclila e derivados de pirimidina análogos como pesticidas | |
| EA201000393A1 (ru) | Новые соединения как антагонисты аденозинового рецептора а1 | |
| BR112016001979A2 (pt) | composto de tetrazolinona e uso do mesmo | |
| Qiu et al. | Multi-view Chinese treebanking | |
| TW200513792A (en) | Photoresist polymer and photoresist composition containing the same | |
| BRPI0800778A2 (pt) | polissiloxano e aditivo tÊxtil contendo polissiloxano | |
| BR0307909A (pt) | Memória compartilhada distribuìda com resiliente à falha | |
| BR112014010413A2 (pt) | comunicação de dados protegida em sistema de computador em rede para fornecer lentes ópticas | |
| BRPI0412340A (pt) | codificador de vìdeo com redução de ruìdo de baixa complexidade | |
| ATE523515T1 (de) | Fotoaktive zusammensetzungen | |
| DK1388542T3 (da) | Anvendelse af hederagenin 3-0-a-L-rhamnopyranosyl((1->2)-[beta-D-glucopyranosyl(1->4)]-a-L-arabinopyranosid eller en ekstrakt fra Pulsatillae radix indeholdende samme som et terapeutisk middel til faste tumorer |